Keyla Sá | International ME/CFS Conference 2026: Autoantibodies analysis in Long COVID and ME/CFS

Dr. Keyla Sà talked about whether autoantibodies contribute to the development of Long COVID and ME/CFS. The research team found that Long COVID patients possessed more than 7,000 unique antibody targets not found in healthy controls, including autoantibodies targeting blood vessels and neurological tissue. Many targets overlapped with those observed in ME/CFS. The findings support the hypothesis that autoimmune mechanisms contribute to neurological symptoms found in Long COVID and ME/CFS. More Details: https://events.mecfs-research.org/en/... 🔔 Subscribe to our channel so you won’t miss any updates or videos from the International ME/CFS Conference 2026! Other interesting links: ➡️ Updated report on the societal cost of Long COVID and ME/CFS in Germany: https://mecfs-research.org/costreport... ➡️ Official Website of the International ME/CFS Conference 2026: https://events.mecfs-research.org/en/... ➡️ ME/CFS Research Register: https://mrr.mecfs-research.org/